Growth Factor Therapy
By Charles Kamen, MD, board-certified neurologist
Growth factor therapy uses concentrated signaling proteins — the same molecules your body releases to heal an injury — to stimulate cell proliferation, differentiation, and new tissue formation at a targeted site. In clinical practice it most often means platelet-rich plasma (PRP), which delivers a natural cocktail of these proteins to support repair and recovery. [1]
Dr. Charles Kamen, MD, a board-certified neurologist at LiveNow Longevity in Las Vegas, incorporates growth factor approaches into regenerative medicine protocols built around the body's own tissue-repair machinery. Individual results vary.
What Are Growth Factors and How Do They Work?
Growth factors are signaling proteins that bind to specific receptors on the surface of cells and switch on the internal programs for proliferation, differentiation, and extracellular matrix production. [1] In plain terms, they are the chemical messages that tell resting cells when to divide, specialize, and rebuild tissue.
Each growth factor is relatively specific to the receptors it fits. When it binds, it triggers a signaling cascade inside the cell that changes which genes are switched on — recruiting new cells, prompting collagen and matrix deposition, and coordinating the orderly sequence of repair. This is why growth factors are fundamental to tissue development, repair, and homeostasis throughout the body.
Where Do Growth Factors Come From?
Growth factors used in therapy come from four main sources, ranging from a patient's own blood to purified and engineered proteins. The most established approach uses the body's own platelets; the others rely on donor, recombinant, or cultured-cell material:
- Autologous (patient's own): PRP provides growth factors from the patient's own platelets
- Allogeneic: Purified or recombinant growth factors from donor or engineered sources
- Conditioned media: Growth factors from cultured cell secretions
- Combination products: Multiple growth factor sources combined
Why PRP Is the Most Common Growth Factor Therapy
Platelet-rich plasma is the most common growth factor therapy in clinical use because it concentrates the patient's own platelets — and with them a full cocktail of growth factors in natural proportions, similar to what the body deploys during spontaneous tissue repair. [2]
This is why PRP is a growth factor concentrate rather than a single-agent drug. How a sample is prepared — the platelet concentration achieved and whether white blood cells are included — measurably changes its biological makeup, which is why standardized protocols matter. [3]
Because free growth factors break down quickly once released, a major research focus is delivery: engineered carriers and controlled-release systems designed to keep these proteins active at the repair site for longer. [4]
Which Growth Factors Matter Most?
Several growth factors do the heavy lifting in regenerative applications, each with a distinct job — from building new blood vessels to laying down collagen. They typically act together rather than in isolation:
- PDGF: Stimulates cell replication, angiogenesis, and collagen formation
- TGF-β: Regulates immune response, cell growth, and matrix production
- VEGF: Promotes new blood vessel formation (angiogenesis)
- EGF: Stimulates epithelial cell proliferation and tissue regeneration
- FGF: Supports connective tissue repair and fibroblast activity
What Conditions Can Growth Factor Therapy Address?
Growth factor therapy is applied across many tissue types where healing is slow or incomplete — orthopedic injuries, chronic wounds, skin, dental, and vascular tissue. The common thread is stimulating repair in tissues that struggle to regenerate on their own:
- Orthopedic: bone, cartilage, tendon, ligament healing
- Wound care: chronic wounds, surgical incisions, ulcers
- Dermatology: skin rejuvenation, scar treatment
- Dental: implant integration, periodontal repair
- Cardiovascular: ischemic tissue, peripheral vascular disease
How Growth Factor Therapy Supports Recovery and Cellular Health
By amplifying the body's own repair signals, growth factor therapy aims to speed recovery, support the rebuilding of connective and musculoskeletal tissue — including tendon, ligament, and muscle — and improve the local environment in which healing happens, rather than simply masking symptoms.
Much of that benefit runs through the blood supply. VEGF and FGF drive angiogenesis, so more new vessels mean more oxygen and nutrients reaching the cells doing the repair — fueling the mitochondrial and cellular activity that rebuilding depends on. These same factors influence the vascular support of nerve tissue, an area where Dr. Kamen's neurology background shapes how he evaluates recovery, and one reason he treats growth factor therapy as part of a comprehensive plan rather than a stand-alone fix.
Key Takeaways
- Growth factors are signaling proteins that bind cell receptors and trigger proliferation, differentiation, and matrix production.
- PRP is the most common growth factor therapy, delivering a natural cocktail of the patient's own growth factors in one concentrate.
- Key growth factors — PDGF, TGF-β, VEGF, EGF, and FGF — work together to drive angiogenesis, cell proliferation, and matrix production.
- Applications span orthopedics, wound care, dermatology, dental, and vascular tissue where healing is slow.
- Growth factor therapy supports the body's own recovery and is often combined with other regenerative approaches.
- Dr. Kamen uses growth factor therapy within comprehensive, individualized regenerative protocols in Las Vegas.
Common Questions
Is growth factor therapy the same as stem cell therapy?
No. Growth factor therapy uses signaling proteins that instruct existing cells to grow, divide, and repair tissue, while stem cell therapy uses living cells that can differentiate into multiple tissue types. The two are complementary approaches, and Dr. Kamen may use them separately or together depending on the goal.
Does growth factor therapy speed up recovery?
Growth factor therapy is designed to accelerate the body's natural repair process by concentrating the signals that recruit cells, build new blood vessels, and lay down new tissue. How much recovery improves depends on the condition, the tissue involved, and individual healing capacity. Individual results vary.
How many growth factor treatments will I need?
Treatment protocols vary by condition and by how each patient responds. Some people improve after a single session; others benefit from a planned series spaced over weeks. Dr. Kamen establishes an individualized protocol after assessing your tissue, goals, and overall health rather than applying a fixed number.
Is growth factor therapy safe?
Growth factor therapy using autologous sources like PRP — drawn from your own blood — has an excellent safety profile because it avoids donor-related reactions. Donor, recombinant, and engineered sources carry different risk profiles. Dr. Kamen reviews the specific safety considerations for whichever approach fits your situation.
Can growth factor therapy help with chronic joint pain?
Growth factor therapy may reduce pain and improve function in some chronic joint and tendon conditions by stimulating repair in tissue that heals slowly on its own. Effectiveness depends on the specific diagnosis, severity, and individual factors, so a proper evaluation comes first. Results are not certain and vary by person.
How long does it take to see results?
Results depend on the tissue being treated and individual healing capacity. Because growth factor therapy works by stimulating your body's own repair process rather than delivering an immediate effect, some improvements may appear within weeks, while more substantial changes can take several months to develop.
Growth factor therapy works with the body's own repair biology rather than against it, supporting recovery and tissue health as part of a broader longevity plan. Consult with Dr. Kamen to explore whether growth factor therapy fits your regenerative medicine goals.
References
- Werner S, Grose R. Physiol Rev. 2003;83(3):835-870. (Regulation of wound healing by growth factors and cytokines).
- Foster TE, et al. Am J Sports Med. 2009;37(11):2259-2272. (Platelet-rich plasma: from basic science to clinical applications).
- Everts P, et al. Int J Mol Sci. 2020;21(20). (Platelet-rich plasma: new performance understandings and therapeutic considerations).
- Zhang J, et al. J Control Release. 2024;320:435-449.
Wondering what’s right for you?
Get a straight answer from board-certified neurologist Dr. Charles Kamen, MD. The evaluation is $88 and is applied toward your protocol if you continue care.